Dataset Viewer
Auto-converted to Parquet Duplicate
letter_date
string
posted_date
string
company
string
company_key
string
issuing_office
string
subject
string
violation_categories
string
response_letter
bool
closeout_letter
bool
letters_to_company
int64
first_letter
string
latest_letter
string
repeat_recipient
bool
fed_uei
string
fed_recipient_name
string
fed_obligated_fy25_plus
float64
fed_top_agency
string
in_ontology
bool
letter_url
string
2026-10-30
2026-11-03
RonanRx, Inc. dba RonanRx
RONANRX INC DBA RONANRX
Center for Drug Evaluation and Research (CDER)
False & Misleading Claims/Misbranded (Telehealth)
Unapproved or misbranded drugs
false
false
1
2026-10-30
2026-10-30
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ronanrx-inc-dba-ronanrx-737905-10302026
2026-10-29
2026-11-03
Conroe Welding Supply, Inc.
CONROE WELDING SUPPLY
Center for Drug Evaluation and Research (CDER)
CGMP/Medical Gases/Adulterated
CGMP other or devices; Adulterated
false
false
1
2026-10-29
2026-10-29
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/conroe-welding-supply-inc-731507-10292026
2026-10-27
2026-11-03
Pritam International Private Limited
PRITAM INTERNATIONAL PRIVATE
Center for Drug Evaluation and Research (CDER)
CGMP/Finished Pharmaceuticals/Adulterated
CGMP drugs; CGMP other or devices; Adulterated
false
false
1
2026-10-27
2026-10-27
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pritam-international-private-limited-738079-10272026
2026-10-27
2026-11-03
whitedragonecigs.com
WHITEDRAGONECIGS COM
Center for Tobacco Products
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Unapproved or misbranded drugs; Adulterated; Tobacco
false
false
1
2026-10-27
2026-10-27
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/whitedragonecigscom-740497-10272026
2026-10-27
2026-11-03
Guangzhou Jiugong Research And Development Biotechnology Co., Ltd.
GUANGZHOU JIUGONG RESEARCH AND DEVELOPMENT BIOTECHNOLOGY
Center for Drug Evaluation and Research (CDER)
CGMP/Finished Pharmaceuticals/Adulterated
CGMP drugs; CGMP other or devices; Adulterated
false
false
1
2026-10-27
2026-10-27
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangzhou-jiugong-research-and-development-biotechnology-co-ltd-737769-10272026
2026-10-27
2026-11-03
Guangdong Bisutang Biotechnology Co., Ltd.
GUANGDONG BISUTANG BIOTECHNOLOGY
Center for Drug Evaluation and Research (CDER)
Refusal to Provide Access to and Copying of Records
null
false
false
1
2026-10-27
2026-10-27
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangdong-bisutang-biotechnology-co-ltd-733939-10272026
2026-10-26
2026-11-03
Bella’s Nutri Shop Inc.
BELLA S NUTRI SHOP
Center for Drug Evaluation and Research (CDER)
Unapproved New Drugs/Misbranded
Unapproved or misbranded drugs
false
false
1
2026-10-26
2026-10-26
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bellas-nutri-shop-inc-737491-10262026
2026-10-26
2026-11-03
Phuoc Loc Tho Herbals, Inc.
PHUOC LOC THO HERBALS
Center for Drug Evaluation and Research (CDER)
Unapproved New Drugs/Misbranded
Unapproved or misbranded drugs
false
false
1
2026-10-26
2026-10-26
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/phuoc-loc-tho-herbals-inc-736860-10262026
2026-10-26
2026-11-03
Ong Tien USA LLC
ONG TIEN USA
Center for Drug Evaluation and Research (CDER)
Unapproved New Drugs/Misbranded
Unapproved or misbranded drugs
false
false
1
2026-10-26
2026-10-26
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ong-tien-usa-llc-737352-10262026
2026-10-26
2026-11-03
New Green Nutrition Inc.
NEW GREEN NUTRITION
Center for Drug Evaluation and Research (CDER)
Unapproved New Drugs/Misbranded
Unapproved or misbranded drugs
false
false
2
2021-10-14
2026-10-26
true
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/new-green-nutrition-inc-737576-10262026
2026-10-26
2026-11-03
Guangdong Bangze Medicine Co., Ltd.
GUANGDONG BANGZE MEDICINE
Center for Drug Evaluation and Research (CDER)
CGMP/Finished Pharmaceuticals/Adulterated
CGMP drugs; CGMP other or devices; Adulterated
false
false
1
2026-10-26
2026-10-26
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangdong-bangze-medicine-co-ltd-734509-10262026
2026-10-26
2026-11-03
Natuzem
NATUZEM
Center for Drug Evaluation and Research (CDER)
Unapproved New Drugs/Misbranded
Unapproved or misbranded drugs
false
false
1
2026-10-26
2026-10-26
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natuzem-737558-10262026
2026-10-26
2026-11-03
Jing Cheong Asia Inc. dba New York Tong Ren Tang
JING CHEONG ASIA INC DBA NEW YORK TONG REN TANG
Center for Drug Evaluation and Research (CDER)
Unapproved New Drugs/Misbranded
Unapproved or misbranded drugs
false
false
1
2026-10-26
2026-10-26
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jing-cheong-asia-inc-dba-new-york-tong-ren-tang-738200-10262026
2026-10-23
2026-10-27
Best Chinese Medicines LLC
BEST CHINESE MEDICINES
Center for Drug Evaluation and Research (CDER)
Unapproved New Drugs
Unapproved or misbranded drugs
false
false
1
2026-10-23
2026-10-23
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/best-chinese-medicines-llc-738556-10232026
2026-10-22
2026-10-27
Sanrace Biotechnology Co., Ltd.
SANRACE BIOTECHNOLOGY
Center for Drug Evaluation and Research (CDER)
CGMP/Finished Pharmaceuticals/Adulterated
CGMP drugs; CGMP other or devices; Adulterated
false
false
1
2026-10-22
2026-10-22
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sanrace-biotechnology-co-ltd-737549-10222026
2026-10-22
2026-10-27
TSP Solutions Pte. Ltd.
TSP SOLUTIONS PTE
Center for Drug Evaluation and Research (CDER)
Request for Records/CGMP/Finished Pharmaceuticals/Adulterated
CGMP drugs; CGMP other or devices; Adulterated
false
false
1
2026-10-22
2026-10-22
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tsp-solutions-pte-ltd-735071-10222026
2026-10-22
2026-10-27
Northland Nuclear Medicine, LLC
NORTHLAND NUCLEAR MEDICINE
Center for Drug Evaluation and Research (CDER)
CGMP/Finished Pharmaceuticals/Adulterated
CGMP drugs; CGMP other or devices; Adulterated
false
false
1
2026-10-22
2026-10-22
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/northland-nuclear-medicine-llc-736893-10222026
2026-10-16
2026-11-03
US Tov Inc. dba US Trading Company
US TOV INC DBA US TRADING
Office of Inspections and Investigations
Foreign Supplier Verification Program (FSVP)
Food safety (FSVP, HACCP, CGMP food)
false
false
1
2026-10-16
2026-10-16
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/us-tov-inc-dba-us-trading-company-739791-10162026
2026-10-14
2026-10-20
Rohto Pharmaceutical Co., Ltd.
ROHTO PHARMACEUTICAL
Center for Drug Evaluation and Research (CDER)
CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated
CGMP drugs; CGMP other or devices; Unapproved or misbranded drugs; Adulterated
false
false
1
2026-10-14
2026-10-14
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/rohto-pharmaceutical-co-ltd-733215-10142026
2026-10-13
2026-10-27
Calibrate IV Hydration
CALIBRATE IV HYDRATION
Center for Biologics Evaluation and Research (CBER)
Unapproved New Drugs/Unlicensed Biological Product Violations
Unapproved or misbranded drugs
false
false
1
2026-10-13
2026-10-13
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/calibrate-iv-hydration-729846-10132026
2026-10-08
2026-10-20
snuskompagniet.com
SNUSKOMPAGNIET COM
Center for Tobacco Products
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Unapproved or misbranded drugs; Adulterated; Tobacco
false
false
1
2026-10-08
2026-10-08
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/snuskompagnietcom-739499-10082026
2026-10-08
2026-10-20
snusi.net
SNUSI NET
Center for Tobacco Products
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Unapproved or misbranded drugs; Adulterated; Tobacco
false
false
1
2026-10-08
2026-10-08
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/snusinet-739447-10082026
2026-10-07
2026-10-20
Olympus Medical Systems Corporation
OLYMPUS MEDICAL SYSTEMS
Center for Devices and Radiological Health
CGMP/QSR/Medical Devices/Adulterated
CGMP other or devices; Adulterated; Medical devices
false
false
3
2022-12-12
2026-10-07
true
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/olympus-medical-systems-corporation-729208-10072026
2026-10-06
2026-10-13
Lovelace Biomedical Research Institute
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Center for Drug Evaluation and Research (CDER)
Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies
null
false
false
1
2026-10-06
2026-10-06
false
MBT9RXJJ7428
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
33,951,877.28
Department of Health and Human Services
true
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lovelace-biomedical-research-institute-725136-10062026
2026-10-06
2026-10-20
Tides Medical LLC
TIDES MEDICAL
Center for Biologics Evaluation and Research (CBER)
Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)
Medical devices
false
false
1
2026-10-06
2026-10-06
false
null
null
null
null
false
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tides-medical-llc-727246-10062026

FDA Warning Letter Ledger: free sample (Tensorust LLC)

Every FDA warning letter in the public index, by company and violation type, with repeat recipients flagged.

Headline: A warning letter is FDA's formal notice that a company is in significant violation and must fix it, but FDA's index lists letters one at a time, with no count of who keeps getting them.

This repository is a free teaser, not the dataset. It holds 25 example rows and a summary table with no names in it. The full file has 3,722 rows and is sold by Tensorust LLC: https://tensorust.com/datasets/fda-warning-letters/.

Files here

file what it is
sample.csv 25 rows of the full file (the same sample shown on tensorust.com)
summary_by_violation_categories.csv row counts by violation categories across the full file, no entity names (groups with fewer than 3 rows are folded into "Other")

Summary by violation categories (largest groups)

Violation categories rows
Unapproved or misbranded drugs; Adulterated; Tobacco 1,208
Unapproved or misbranded drugs 511
CGMP drugs; CGMP other or devices; Adulterated 446
Food safety (FSVP, HACCP, CGMP food) 338
CGMP other or devices; Adulterated; Food safety (FSVP, HACCP, CGMP food) 204
Unapproved or misbranded drugs; Internet / COVID claims 160
(blank) 131
CGMP other or devices; Adulterated; Medical devices 101
CGMP drugs; CGMP other or devices; Unapproved or misbranded drugs; Adulterated 66
Adulterated; Compounding / outsourcing 59
Adulterated; Food safety (FSVP, HACCP, CGMP food) 48
Adulterated; Medical devices 45
TOTAL 3,722

Full table: summary_by_violation_categories.csv.

What the full file has

  • 3,722 rows
  • Key fields: letter_date, posted_date, company, company_key, issuing_office, subject, violation_categories, response_letter, closeout_letter, letters_to_company
  • Parquet and CSV, a README with sources, method and limits, and the build script
  • Free 25-row sample (no personal contact data)

Coverage: 3,722 letters to 3,542 companies; the index FDA keeps online. FDA index read Nov 6, 2026.

Columns in the full file

column meaning
letter_date Date on the warning letter
posted_date Date FDA posted it
company Recipient company
company_key Ontology organization key
issuing_office FDA center or office that issued it
subject Subject line (violation type) as FDA lists it
violation_categories Tensorust categories derived from the subject
response_letter FDA posted a response letter
closeout_letter FDA posted a close-out letter (issues resolved)
letters_to_company Letters to the same company in the index
first_letter Earliest letter to the company in the index
latest_letter Latest letter to the company
repeat_recipient Two or more letters to the same company
fed_uei UEI of a matching federal award recipient
fed_recipient_name Matching USAspending recipient
fed_obligated_fy25_plus Its obligations FY2025 onward (USD)
fed_top_agency Top awarding agency
in_ontology Company key exists in the Tensorust ontology
letter_url The letter on fda.gov

Get the full file

tier price includes
Warning letter file $900 All 3,722 warning letters in FDA's index with violation categories, close-out status, repeat-recipient counts and links.
Weekly warning letter feed $6,000 a year New letters each week as FDA posts them (it posts on Tuesdays), categorized, with repeat recipients flagged. Up to 5 users.
Quality and diligence license $18,000 a year The weekly feed firm-wide, screening of your supplier or target list, and FDA 483 and import alert joins on request.

Email mattbusel@tensorust.com with the tier and a billing contact, and we will send a proper invoice (ACH or card). The file is delivered once the invoice is paid. Details and the live sample: https://tensorust.com/datasets/fda-warning-letters/. All datasets: https://tensorust.com/datasets/

Method and limits

The table behind FDA's warning letter page is read in four requests, two seconds apart. Letters to individual physicians and clinical investigators are removed. Company names are normalized with the ontology key to count repeat recipients and to join USAspending recipients. Categories are keyword rules on FDA's subject line.

Not FDA Form 483 observations or import alerts, and not every historical letter: it is the index FDA keeps online. A close-out flag is only set when FDA has posted one. Not regulatory advice. Letters to individual physicians and investigators are excluded.

Sources

License

The sample and summary here are free to view, analyze and cite with attribution to "Tensorust LLC, https://tensorust.com/datasets/fda-warning-letters/". The full dataset is licensed separately per tier. No resale or redistribution of Tensorust data without a written license.

Tensorust LLC, Tuckahoe NY. mattbusel@tensorust.com | https://tensorust.com

Downloads last month
47